Literature DB >> 11162488

Genomic sequence and structure of the human ABCG1 (ABC8) gene.

S Lorkowski1, S Rust, T Engel, E Jung, K Tegelkamp, E A Galinski, G Assmann, P Cullen.   

Abstract

The human ATP-binding cassette half transporter G1 (hABCG1) may play a role in cholesterol transport in macrophages. Using RACE assays we determined the structure of this gene. The hABCG1 gene spans more than 97 kb comprising 20 exons, 20 kb and 5 exons more than hitherto described. Four of the novel exons are upstream and one is downstream of previous exon 1, and they are predicted to encode at least five novel transcripts. We also detected two separate promoters, upstream of exons 1 and 5, respectively. The region 650 bp upstream of exon 1 was predicted to contain putative binding sites for SP1 and nuclear factor kappaB (NF-kappaB), but no sterol response elements (SREs) or retinoid X receptor (RXR) binding sites. The region 650 bp upstream of exon 5 contained 19 possible SP1 binding sites, one possible SRE, two possible NF-kappaB, and two putative RXR binding sites. Nevertheless, both promoters responded in macrophages to stimulation by hydroxycholesterol and retinoic acid. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162488     DOI: 10.1006/bbrc.2000.4089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population.

Authors:  V H S Zago; D Z Scherrer; E S Parra; N B Panzoldo; F Alexandre; E R Nakandakare; E C R Quintão; E C de Faria
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

Review 2.  ATP-binding cassette, subfamily G (ABCG family).

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pflugers Arch       Date:  2006-09-16       Impact factor: 3.657

Review 3.  High-density lipoprotein and atherosclerosis: Roles of lipid transporters.

Authors:  Yoshinari Uehara; Keijiro Saku
Journal:  World J Cardiol       Date:  2014-10-26

Review 4.  The ABCG family of membrane-associated transporters: you don't have to be big to be mighty.

Authors:  Ian D Kerr; Ameena J Haider; Ingrid C Gelissen
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening.

Authors:  Katrin Stolle; Benedikt Weitkamp; Jürgen Rauterberg; Stefan Lorkowski; Paul Cullen
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

Review 6.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

7.  Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet.

Authors:  Federica Basso; Marcelo J Amar; Elke M Wagner; Boris Vaisman; Beverly Paigen; Silvia Santamarina-Fojo; Alan T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2006-10-17       Impact factor: 3.575

8.  Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels.

Authors:  Gavin Tansley; Daniel T Holmes; Dieter Lütjohann; Elizabeth Head; Cheryl L Wellington
Journal:  Curr Gerontol Geriatr Res       Date:  2012-05-09

9.  Cellular Localization and Trafficking of the Human ABCG1 Transporter.

Authors:  Edward B Neufeld; Katherine O'Brien; Avram D Walts; John A Stonik; Steven J Demosky; Daniela Malide; Christian A Combs; Alan T Remaley
Journal:  Biology (Basel)       Date:  2014-11-14

10.  Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol.

Authors:  Lei Xu; Yi-Ru Wang; Pei-Cheng Li; Bo Feng
Journal:  Lipids Health Dis       Date:  2016-09-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.